TOP TIERMARKET NEWSWIRE
SEC Form 4 history

ADARX PHARMACEUTICAL (ADRX) insider trades

ADARX PHARMACEUTICAL (ADRX) insider trading activity (SEC Form 4). Over the trailing 90 days, ADRX insiders filed 5 purchases totalling $87.7M and 0 sales totalling $0 — net BUYING of $87.7M. Most recent filing: Sep 30, 2026. Insider transactions are a Pro-tier alertable signal in the live Top Tier Newswire terminal — Form 4 filings reach the wire within minutes of acceptance by the SEC. Data shown publicly here is delayed 4 hours.

Public view, delayed 4h. Real-time alerting on insider filings is a Pro feature.Open in the live terminal →
Buys (90d)
5
$87.7M
Sells (90d)
0
$0
Net (90d)
+$87.7M
net buying
Most recent
Sep 30, 2026

Recent transactions

FiledInsiderRoleTypeSharesPriceValue
Sep 30, 2026Chimovits ErezDirP Purchase—$17.00$1.0Mfiling
Sep 30, 2026Gordon Carl LDir, 10%P Purchase—$17.00$16.1Mfiling
Sep 30, 2026Orbimed Advisors LLCDir, 10%P Purchase—$17.00$16.1Mfiling
Sep 29, 2026Sr One Capital Management, LLC10%P Purchase—$17.00$27.2Mfiling
Sep 29, 2026George SimeonDir, 10%P Purchase—$17.00$27.2Mfiling